Have any questions?
+44 1234 567 890
Urologischer Nachwuchs | Best Paper
2025
Dr. med. univ. Nastasiia Artamonova, Bakk. Phil. | Medizinische Universität Innsbruck | Universitätsklinik für Urologie
The Clinical Trajectory of Prostate Cancer Patients Harboring Rare Histological Subtypes – A Retrospective Cohort Trial
Dr. med. univ. Hanna Hagen | Klinik Favoriten | Urologische Ambulanz
Sexual function and Its Association with Psychosocial Factors after Penile Inversion Vulvo-Vaginoplasty without Scrotal Skin Grafts: A Retrospective Study Ssing the oMtFSFI
Dr. med. univ. Andreas Banner | Klinik Favoriten Wien | Urologische Ambulanz
Infectious complications in patients undergoing transrectal prostatebiopsy with ciprofloxacin compared to fosfomycin-trometamol
Dr. med. univ. Ozan Yurdakul | Medizinische Universität Wien | Universitätsklinik für Urologie
Impact of Personnel Scarcity on Urolithiasis Treatment: A Comparative Study of the Pre- and Post-Pandemic Eras
Dr. Giulia Giannini | Medizinische Universität Innsbruck | Universitätsklinik für Urologie
Safety and Efficacy of 177Lu-PSMA Therapy Following 223Radium Treatment: A Retrospective Multinational Real-World Analysis
Dr. med. univ. Heidemarie Ofner | Medizinische Universität Wien | Universitätsklinik für Urologie
Does PARP1 up-regulation correlate with PSMA expression in patients with metastatic castration-resistant prostate cancer studied with [18F]PARPi and [68Ga] PSMA PET/CT?
2024
Dr. med. univ. Nastasiia Artamonova, Bakk. Phil. | Medizinische Universität Innsbruck | Universitätsklinik für Urologie
Impact of Renin-Angiotensin System Inhibitors on Disease Characteristics in Patients with Localized Prostate Cancer Treated with Radical Prostatectomy: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study (European Urology Open Science)
Dr. med. univ. Andreas Banner | Klinik Favoriten | Urologische Abteilung
Resource use in the last year of life of prostate cancer patients—A register-based analysis (Prostate Cancer and Prostatic Diseases)
Dr. med. univ. Nicolai Hübner | Medizinische Universität Wien | Universitätsklinik für Urologie
Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET (Urologic Oncology: Seminars and Original Investigations)
Dr. med. univ. Mona Kafka | Medizinische Universität Innsbruck | Universitätsklinik für Urologie
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study (Clinical Genitourinary Cancer)
2023
Dr. Mona Kafka | Medizinische Universität Innsbruck | Universitätsklinik für Urologie
Real-world Outcomes and Predictive Biomarkers for 177 Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study
Dr. med. univ. Lukas Scheipner | Medizinische Universität Graz | Universitätsklinik für Urologie
Characteristics of incidental prostate cancer in the United States
2022
Mag. Dr. Melanie Hassler-Di Fratta, Ph.D. | Medizinische Universität Wien | Universitätsklinik für Urologie
Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis
Dr. Nicolai Hübner | Medizinische Universität Wien | Universitätsklinik für Urologie
Feasibility and Optimal Time Point of [68Ga] Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery
Dr. Stephan Brönimann | Medizinische Universität Wien | Universitätsklinik für Urologie
Time trend analysis of incidence of testicular cancer in Austria during the last four decades
Dr. Andrea Katharina Lindner | Medizinische Universität Innsbruck | Universitätsklinik für Urologie
Do we need repeated CT imaging in uncomplicated blunt renal injuries? Experiences of a high-volume urological trauma centre
2021
Dr. Dong-Ho Mun
Difference in Incontinence Pad Use between Patients after Radical Prostatectomy and Cancer-Free Population with Subgroup Analysis for Open vs. Minimally Invasive Radical Prostatectomy:
A Descriptive Analysis of Insurance Claims-Based Data
Dr. Judith Stangl-Kremser
Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia
Dr. Maximilian Pallauf
Adherence to the EAU Guideline Recommendations for Local Tumor Treatment in Penile Cancer: Results of the European PROspective Penile Cancer Study Group Survey (E-PROPS)
Priv.-Doz. Dr. David D’Andrea
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer
Dr. Michael Ladurner
Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer
Dr. Gennadi Tulchiner, PhD
The “COVID-19 Pandemic Gap” and Its Influence on Oncologic Outcomes of Bladder Cancer
2020
Dr. David D'Andrea
Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer
Dr. Renate Pichler
Amplification of 7p12 is associated with pathologic nonresponse to neoadjuvant chemotherapy in muscle-invasive bladder cancer
Dr. Andrea Katharina Lindner
Amplification of 7p12 is associated with pathologic nonresponse to neoadjuvant chemotherapy in muscle-invasive bladder cancer
2019
Dr. Andrea Katharina Lindner
Organ‑sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival
Dr. Judith Stangl-Kremser
Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder
2018
Dr. Klaus Eredics
Bladder cancer in nonagenarians: A multicenter study of 123 patients
Dr. Bernhard Grubmüller
PSMA ligand PET/MRI for primary prostate cancer: Staging performance and clinical impact
2017
Dr. Bernhard Grubmüller
68Ga-PSMA 11 Ligand PET Imaging in Patients with Biochemical Recurrence after Radical Prostatectomy – Diagnostic Performance and Impact on Therapeutic Decision Making
Dr. Maximilian Seles
Blood Platelet Volume Represents a Novel Factor in Patients with Non-metastastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores
2016
Dr. Klaus Eredics
Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitätspartnerschaft Urologie (QuapU)
Dr. Stephan Seklehner
Does a retrograde pyelography prior to ureteroscopy influence stone-free rates and complication rates in ureteral calculi?
2015
Dr. Tanja Gschliesser
Geschlechtergetrennte Analyse der Österreichischen Zystektomiedatenbank
Geschlechtergetrennte Analyse der Österreichischen Zystektomiedatenbank
Dr. Ingrid Schauer
Sinnhaftigkeit der Kathetereinlage im Rahmen eines hochfieberhaften Harnwegsinfekts: eine prospektiv-randomisierte Studie
Sinnhaftigkeit der Kathetereinlage im Rahmen eines hochfieberhaften Harnwegsinfekts: eine prospektiv-randomisierte Studie